The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

The agency's website indicates HHS Secretary Robert F. Kennedy Jr. adopted the previous advisory panel's suggestion to expand access on June 25. AP also reports on FDA vaccine chief Vinay Prasad's ...

With the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

A prominent paediatrician on Sunday urged people to take more precautions against a common virus known as RSV, saying cases ...

Primary Source JAMA Source Reference: Surie D, et al "RSV vaccine effectiveness against hospitalization among US adults 60 years and older" JAMA 2024; DOI: 10.1001/jama.2024.15775.

RSV is a common cause of lower respiratory tract infections (infections of the lungs or airways below the voice box) in infants. In 2019, around 33 million children under five years of age had a lower ...

June 17, 2025 – The FDA has expanded the use of Moderna's respiratory syncytial virus (RSV) shot to all adults, with some limits on who can get it. First approved in 2024 for people 60 or older ...

The Food and Drug Administration (FDA) has expanded the approval of mResvia (respiratory syncytial virus [RSV] vaccine) to include active immunization in individuals 18 through 59 years of age who ...